{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:28:50Z","timestamp":1767893330002,"version":"3.49.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,3,15]]},"DOI":"10.2169\/internalmedicine.7774-21","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T22:09:52Z","timestamp":1629756592000},"page":"887-890","source":"Crossref","is-referenced-by-count":4,"title":["Novel LG1 Mutations in Agrin Causing Congenital Myasthenia Syndrome"],"prefix":"10.2169","volume":"61","author":[{"given":"Ping","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis 14: 57, 2019.","DOI":"10.1186\/s13023-019-1025-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 14: 420-434, 2015.","DOI":"10.1016\/S1474-4422(14)70201-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gan SY, Yang HY, Xiao T, Pan Z, Wu L. AGRN gene mutation leads to congenital myasthenia syndromes: a pediatric case report and literature review. Neuropediatrics 51: 364-367, 2020.","DOI":"10.1055\/s-0040-1708534"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Vanhaesebrouck AE, Beeson D. The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies. Curr Opin Neurol 32: 696-703, 2019.","DOI":"10.1097\/WCO.0000000000000736"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vrinten C, van der Zwaag AM, Weinreich SS, Scholten RJ, Verschuuren JJ. Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes. Cochrane Database Syst Rev 2014: CD010028, 2014.","DOI":"10.1002\/14651858.CD010028.pub2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ohno K, Ohkawara B, Ito M. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders. Expert Opin Ther Targets 21: 949-958, 2017.","DOI":"10.1080\/14728222.2017.1369960"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Farmakidis C, Pasnoor M, Barohn RJ, Dimachkie MM. Congenital myasthenic syndromes: a clinical and treatment approach. Curr Treat Options Neurol 20: 36, 2018.","DOI":"10.1007\/s11940-018-0520-7"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Nicole S, Chaouch A, Torbergsen T, et al. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy. Brain 137: 2429-2443, 2014.","DOI":"10.1093\/brain\/awu160"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Xi J, Yan C, Liu WW, et al. Novel SEA and LG2 Agrin mutations causing congenital myasthenic syndrome. Orphanet J Rare Dis 12: 182, 2017.","DOI":"10.1186\/s13023-017-0732-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Scotton P, Bleckmann D, Stebler M, et al. Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin. J Biol Chem 281: 36835-36845, 2006.","DOI":"10.1074\/jbc.M607887200"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tezuka T, Inoue A, Weatherbee SD, et al. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses. Proc Natl Acad Sci 111: 16556-16561, 2014.","DOI":"10.1073\/pnas.1408409111"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Tsim KW, Ruegg MA, Escher G, Kr\u00f6ger S, McMahan UJ. cDNA that encodes active agrin. Neuron 8: 677-689, 1992.","DOI":"10.1016\/0896-6273(92)90089-V"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rupp F, Oz\u00e7elik T, Linial M, Peterson K, Francke U, Scheller R. Structure and chromosomal localization of the mammalian agrin gene. J Neurosci 12: 3535-3544, 1992.","DOI":"10.1523\/JNEUROSCI.12-09-03535.1992"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang A, Xiao Y, Huang P, et al. Novel NtA and LG1 mutations in agrin in a single patient causes congenital myasthenic syndrome. Front Neurol 11: 239, 2020.","DOI":"10.3389\/fneur.2020.00239"},{"key":"15","doi-asserted-by":"crossref","first-page":"e132023","DOI":"10.1172\/jci.insight.132023","volume":"5","author":"B Ohkawara","year":"2020","unstructured":"15. Ohkawara B, Shen XM, Selcen D, et al. Congenital myasthenic syndrome-associated agrin variants affect clustering of acetylcholine receptors in a domain-specific manner. JCI Insight 5: e132023, 2020.","journal-title":"JCI Insight","ISSN":"https:\/\/id.crossref.org\/issn\/2379-3708","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/6\/61_7774-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T03:31:22Z","timestamp":1647660682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/6\/61_7774-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7774-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"7774-21"}}